Franklin Resources Inc Cyma Bay Therapeutics, Inc. Transaction History

Franklin Resources Inc

$304 Billion
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$12.63 - $24.47 $505,048 - $978,506	-39,988 Reduced 1.21%	3,267,927 $77.2 Million
Q3 2023 Nov 13, 2023	BUY	$10.86 - $17.62 $389,950 - $632,681	35,907 Added 1.1%	3,307,915 $49.3 Million
Q2 2023 Aug 11, 2023	BUY	$7.47 - $10.95 $352,180 - $516,248	47,146 Added 1.46%	3,272,008 $35.8 Million
Q1 2023 May 12, 2023	BUY	$5.88 - $9.59 $18.8 Million - $30.7 Million	3,201,765 Added 13862.25%	3,224,862 $28.1 Million
Q3 2022 Nov 14, 2022	SELL	$2.77 - $4.25 $3,786 - $5,809	-1,367 Reduced 5.59%	23,097 $81,000

Q2 2022 Aug 11, 2022	SELL	$1.72 - $3.39 $1,699 - $3,349	-988 Reduced 3.88%	24,464 $72,000
Q1 2022 May 13, 2022	SELL	$2.77 - $3.64 $14,905 - $19,586	-5,381 Reduced 17.45%	25,452 $79,000
Q4 2021 Feb 11, 2022	SELL	$3.23 - $4.6 $269,333 - $383,570	-83,385 Reduced 73.01%	30,833 $104,000
Q3 2021 Nov 12, 2021	BUY	$3.47 - $4.42 $319,986 - $407,590	92,215 Added 419.1%	114,218 $417,000
Q1 2021 May 13, 2021	SELL	$4.23 - $6.55 $875 - $1,355	-207 Reduced 0.93%	22,003 $100,000
Q4 2020 Feb 10, 2021	SELL	$5.73 - $9.03 $1,587 - $2,501	-277 Reduced 1.23%	22,210 $127,000
Q3 2020 Nov 12, 2020	BUY	$3.32 - $7.24 $74,656 - $162,805	22,487 New	22,487 $163,000
Q2 2020 Aug 13, 2020	SELL	$1.41 - $4.25 $1.62 Million - $4.89 Million	-1,151,356 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$6.05 - $13.66 $170,005 - $383,846	28,100 Added 2.5%	1,151,356 $8.24 Million
Q1 2019 May 14, 2019	SELL	$8.16 - $13.42 $4.98 Million - $8.2 Million	-610,844 Reduced 35.23%	1,123,256 $14.9 Million
Q3 2018 Nov 13, 2018	SELL	$10.88 - $14.52 $702,848 - $937,992	-64,600 Reduced 3.59%	1,734,100 $19.2 Million
Q1 2018 May 10, 2018	BUY	$9.0 - $15.16 $3.15 Million - $5.31 Million	350,000 Added 24.16%	1,798,700 $23.4 Million
Q4 2017 Feb 14, 2018	SELL	$7.67 - $9.31 $393,471 - $477,603	-51,300 Reduced 3.42%	1,448,700 $13.3 Million
Q3 2017 Nov 13, 2017	BUY	$5.95 - $8.26 $8.93 Million - $12.4 Million	1,500,000	1,500,000 $12.1 Million

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.88M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account